Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neuren nerve protection research published
The research has been published in the international peer-reviewed journal Experimental Cell Research. The paper outlines the discovery of novel genes that code for a neural regeneration peptide
The research has been published in the international peer-reviewed journal Experimental Cell Research. The paper outlines the discovery of novel genes that code for a neural regeneration peptide
AI-700, currently in phase III clinical trials, is Acusphere’s leading product candidate. The commercial scale batch, produced at the company’s commercial manufacturing facility in Tewksbury, Massachusetts, met all
The phase I study will examine whether high doses of Phytosel, INB Biotechnologies’ proprietary plant-derived oral formulation of selenium, can reduce the negative side effects of two chemotherapeutic
Effective immediately, Ricerca will begin developmental work on PhytoMedical’s BDC-03 compound for cachexia, a devastating muscle wasting condition that afflicts 25% of all AIDS patients and upwards of
The license agreement gives HepaLife exclusive rights to five issued patents. Under the terms of the agreement, HepaLife agreed to pay Michigan State University (MSU) undisclosed milestone payments
Cethrin, a recombinant protein-based inhibitor of Rho signaling, is co-delivered with a fibrin sealant and administered once directly onto the surface of the spinal cord during spinal decompression
Although doctors have known that the cervical tissue at the opening to the womb can harbor multiple human papillomavirus (HPV) types, this study is the first to document
The filing is based on impressive phase III trial data, which show that the addition of Avastin to standard chemotherapy as a primary treatment for advanced breast cancer
The State Food and Drug Administration (SFDA)’s implementation plan requires that provincial drug regulatory departments carry out a full investigation of manufacturers of drug raw materials and drug
In an approvable letter to the company the FDA indicated that the agency required an additional study because it believed the results of the three trials conducted to